SERB Pharma Inks Licensing Deal with SFJ for Brilinta Reversal Agent By Mark TerryMay 12, 2023 Philadelphia-based SERB Pharmaceuticals has inked a licensing deal with San Francisco’s SFJ Pharmaceuticals for [….]
Weekly Quick Hits (Greater Philly) – Week of May 8, 2023
Published on :Weekly Quick Hits (Greater Philly) – Week of May 8, 2023 By Mark TerryMay 12, 2023 Funding, Awards and Collaborations Interius Announces Manufacturing Partnership with WuXi Advanced Therapies Philadelphia-based Interius [….]